Additional file 1: of Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction

Figure S1. Effects of different doses of agomir-133 (15, 25, 40 nM) on expression of miR-133 in ischemic myocardium. Figure S2. MicroRNA profile changes between sham and MI mice treated with or without t-AUCB. Figure S3. Effect of t-AUCB on primary neonatal mouse ventricular myocytes viability. Table S1. Significantly up-regulated miRNAs in ischemic myocardium between sham-operated animals with MI mice treated with or without t-AUCB. Table S2. Significantly down-regulated miRNAs in ischemic myocardium between sham-operated animals with MI mice treated with or without t-AUCB. (DOCX 1178 kb